These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18981157)

  • 41. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
    Chang R; Yi S; Tan X; Huang Y; Wang Q; Su G; Zhou C; Cao Q; Yuan G; Kijlstra A; Yang P
    Br J Ophthalmol; 2018 Feb; 102(2):282-290. PubMed ID: 28972028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is sprint exercise a leptin signaling mimetic in human skeletal muscle?
    Guerra B; Olmedillas H; Guadalupe-Grau A; Ponce-González JG; Morales-Alamo D; Fuentes T; Chapinal E; Fernández-Pérez L; De Pablos-Velasco P; Santana A; Calbet JA
    J Appl Physiol (1985); 2011 Sep; 111(3):715-25. PubMed ID: 21659488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.
    Wain JH; Kirby JA; Ali S
    Clin Exp Immunol; 2002 Mar; 127(3):436-44. PubMed ID: 11966759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
    Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2005 Nov; 142(2):285-91. PubMed ID: 16232215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
    Yu JH; Kim KH; Kim H
    Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.
    Baker BJ; Qin H; Benveniste EN
    Glia; 2008 Aug; 56(11):1250-62. PubMed ID: 18571793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2).
    Sironi M; Martinez FO; D'Ambrosio D; Gattorno M; Polentarutti N; Locati M; Gregorio A; Iellem A; Cassatella MA; Van Damme J; Sozzani S; Martini A; Sinigaglia F; Vecchi A; Mantovani A
    J Leukoc Biol; 2006 Aug; 80(2):342-9. PubMed ID: 16735693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes.
    Dai X; Sayama K; Tohyama M; Shirakata Y; Yang L; Hirakawa S; Tokumaru S; Hashimoto K
    Int Immunol; 2008 Jul; 20(7):901-9. PubMed ID: 18492658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JAK kinases overexpression promotes in vitro cell transformation.
    Knoops L; Hornakova T; Royer Y; Constantinescu SN; Renauld JC
    Oncogene; 2008 Mar; 27(11):1511-9. PubMed ID: 17873904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1.
    Yang YH; Toh ML; Clyne CD; Leech M; Aeberli D; Xue J; Dacumos A; Sharma L; Morand EF
    J Immunol; 2006 Dec; 177(11):8148-53. PubMed ID: 17114490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
    Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
    Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The synthetic α-bromo-2',3,4,4'-tetramethoxychalcone (α-Br-TMC) inhibits the JAK/STAT signaling pathway.
    Pinz S; Unser S; Brueggemann S; Besl E; Al-Rifai N; Petkes H; Amslinger S; Rascle A
    PLoS One; 2014; 9(3):e90275. PubMed ID: 24595334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.